Investing in Pacira BioSciences, Inc. (PCRX)  ➔  Intrinsic value

Prev. close$57.86 
ModelValueUpside
Chepakovich$13.03-77%
Graham-Dodd$26.39-54%
Graham$54.29-6%
Previous Close$57.86  
Valuation MethodValuePotential 
Chepakovich Model$13.03-77%recalculate
Graham-Dodd$26.39-54%recalculate
Graham Formula$54.29-6%recalculate

Latest news

Company description

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for health care practitioners and their patients in the United States. The company develops products based on its proprietary DepoFoam product delivery technology that encapsulates drugs without altering their molecular structure. It offers EXPAREL, a non-opioid medication administered at the time of surgery to control pain while reducing opioid requirements; and iovera system, a handheld cryoanalgesia device used to deliver controlled doses of cold temperature only to targeted nerves. The company has collaboration with Aetna. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was founded in 2006 and is headquartered in Parsippany, New Jersey.